Retatrutide is currently being studied for several metabolic conditions, including: Cardiovascular disease Chronic lower back pain Knee osteoarthritis Obesity and chronic weight management Obstructive sleep apnea Type 2 diabetes Like other incretin-based drugs, retatrutide is given as a weekly injection during clinical trials
Response times vary, and the lack of published pricing means you may not know the exact cost until this stage
If you notice signs of depression, anxiety, or mood instability, its important to discuss these with your healthcare provider
What GLP-1s do in your body: Stimulate insulin release from pancreatic beta cells Slow gastric emptying, which reduces appetite Get metabolized primarily by the liver Are cleared partially through kidney function Have unknown long-term effects on thyroid C-cells Nearly half of patients stop GLP-1 therapy within the first year
whole foods, adequate protein, and fiber-rich vegetables align with how the medication signals satiety to your brain
It is a potent intracellular antioxidant, as important as L-glutathione